QCG
AMAG

Quadrant Capital Group’s AMAG Pharmaceuticals AMAG Stock Holding History

Quadrant Capital Group’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-35
Closed – – 2114
2016
Q3 		$0 Buy
+35
New +$875 ﹤0.01% 2106
2016
Q1 		– Sell
-7
Closed – – 2073
2015
Q4 		$0 Sell
7
-20
-74% -$646 ﹤0.01% 1763
2015
Q3 		$0 Hold
27
– – ﹤0.01% 1426
2015
Q2 		$1K Buy
+27
New +$1.7K ﹤0.01% 1117

Other funds holding AMAG

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quadrant Capital Group's AMAG Position: Q4 2016 in Review

Quadrant Capital Group sold out of AMAG Pharmaceuticals (AMAG) in Q4 2016, closing a stake of 35 shares.

Quadrant Capital Group first reported a position in AMAG in Q2 2015 and held it in 4 quarters. The position peaked at $1K in Q2 2015. 206 funds tracked by Wall St. Rank hold AMAG as of Q4 2016.

  • Quadrant Capital Group reported no remaining AMAG Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Quadrant Capital Group sold 35 AMAG Pharmaceuticals shares in Q4 2016.
  • Quadrant Capital Group first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 4 quarters.
  • Quadrant Capital Group's AMAG Pharmaceuticals position peaked at $1K in Q2 2015.
  • 206 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2016.

Based on Quadrant Capital Group's 13F filing for Q4 2016, filed 11 Jan 2017.